| Conferences \ Extracellular Vesicles 2022: Biology, Disease & Medicine \ Agenda \ Emilia Scharrig |
| Register | Login |
Biomarker Analysis of Extracellular Vesicles (EVs) Derived from Peripheral Blood Mononuclear Cells (PBMCs) of Patients with Inflammatory Bowel Disease (IBD)Wednesday, 14 September 2022 at 16:00  Add to Calendar ▼2022-09-14 16:00:002022-09-14 17:00:00Europe/LondonBiomarker Analysis of Extracellular Vesicles (EVs) Derived from Peripheral Blood Mononuclear Cells (PBMCs) of Patients with Inflammatory Bowel Disease (IBD)Extracellular Vesicles 2022: Biology, Disease and Medicine in SeattleSeattleSELECTBIOenquiries@selectbiosciences.comIBD is a hyperinflammatory disorder that manifests with a severely compromised intestine, combined with dysregulation of the immune system. Although several factors have been associated with the disease, the pathophysiological mechanism is still not well-understood. Recent research suggests that EVs may be involved in the progression of IBD inflammation; still little is known about the contribution of immune cells-derived EVs to this pathology. To find out potential biomarkers of IBD we evaluated the protein composition of PBMCs-derived EVs from IBD patients and healthy controls. Most of the protein content (over 90%) of PBMC-derived EVs was shared among all the analyzed samples. A unique set of proteins present in IBD-EVs that has the potential to be used as biomarkers of the disease was identified. The specific content of the EVs and their variations are telling the story of a disease. |
Add to Calendar ▼2022-09-13 00:00:002022-09-14 00:00:00Europe/LondonExtracellular Vesicles 2022: Biology, Disease and MedicineExtracellular Vesicles 2022: Biology, Disease and Medicine in SeattleSeattleSELECTBIOenquiries@selectbiosciences.com
